FDA approves much-debated Alzheimer’s drug panned by experts

  • by

WASHINGTON (AP) — Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease.

Leave a Reply

Your email address will not be published. Required fields are marked *